PMN-310

N/A

Report date: 2023/11/28 15:59:29

Base Information

Drug NamePMN-310
Drug Alias NamePMN-310huPMN-310
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProMIS Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A